Catalyst Wire Dossier Catalyst Wire Dossier

Glycopyrronium/Formoterol Fumarate Fixed-dose Combination

glycopyrronium/formoterol fumarate · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glycopyrronium/Formoterol Fumarate Fixed-dose Combination, covering 2019-05-22 to 2019-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease [Phase 3]

See pricing